이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

PetMed Express 관리

관리 기준 확인 1/4

PetMed Express' CEO는 Sandra Campos, Apr2024 에 임명되었습니다 의 임기는 1년 미만입니다. 는 $ 5.13K 가치에 해당하는 회사 주식의 0.008% 직접 소유합니다. 5.13K. 경영진과 이사회의 평균 재임 기간은 각각 0.3 년과 1.8 년입니다.

주요 정보

Sandra Campos

최고 경영자

US$128.2k

총 보상

CEO 급여 비율	n/a
CEO 임기	less than a year
CEO 소유권	0.008%
경영진 평균 재임 기간	less than a year
이사회 평균 재임 기간	1.9yrs

최근 관리 업데이트

Recent updates

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Aug 09

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

Jun 12

PetMed Express CFO to leave post today, by remain with company over transition period

Aug 02

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

Jul 29

PetMed Express FQ1 2023 Earnings Preview

Jul 24

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

Jul 15

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

Jul 04

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

May 26

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

May 13

CEO

Sandra Campos (57 yo)

less than a year

테뉴어

US$128,183

보상

Ms. Sandra Y. Campos is Independent Director of PetMed Express, Inc. from May 17, 2023 and serves as its CEO and President since April 29, 2024. She serves as an Independent Director at Commerce Fabric, In...

리더십 팀

이름	위치	테뉴어	보상	소유권
Sandra Campos	President	less than a year	US$128.18k	0.0079% $ 6.0k
Christine Chambers	Treasurer & Secretary	1.9yrs	US$401.34k	0.082% $ 62.3k
Robyn DElia	Chief Financial Officer	no data	데이터 없음	데이터 없음
Caroline Conegliano	Chief Operating Officer	less than a year	데이터 없음	데이터 없음
Doug Krulik	Chief Accounting Officer	less than a year	데이터 없음	데이터 없음
Mark Moseley	Chief Technology & Information Officer	2.7yrs	데이터 없음	0.20% $ 154.6k
Carla Dodds	Chief Marketing Officer	less than a year	데이터 없음	데이터 없음
Jacqueline Smith	Vice President of People	2.7yrs	데이터 없음	0.066% $ 50.2k
Umesh Sripad	Chief Digital & Technology Officer	less than a year	데이터 없음	데이터 없음
Wendy Zalai	Corporate Controller & Corporate Secretary	3.6yrs	데이터 없음	데이터 없음

0.4yrs

평균 재임 기간

경험이 풍부한 관리: PETS 의 관리팀은 경험 (평균 재직 기간 0.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Sandra Campos	President	1.3yrs	US$128.18k	0.0079% $ 6.0k
Gian Fulgoni	Independent Director	21.8yrs	US$150.98k	0.55% $ 412.2k
Diana Purcel	Independent Director	2.4yrs	US$139.53k	0.058% $ 43.7k
Leah Solivan	Independent Director	less than a year	데이터 없음	데이터 없음
Leslie C. Campbell	Independent Chairman of the Board	6.2yrs	US$143.07k	0.21% $ 156.4k
Justin Mennen	Independent Director	less than a year	데이터 없음	데이터 없음

1.9yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: PETS 의 이사회는 경험(평균 재직 기간 1.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

PetMed Express 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

PetMed Express, Inc. Appoints Robyn DElia as Chief Financial Officer, Effective September 16, 2024

Petmed Express, Inc. Appoints Doug Krulik as Chief Accounting Officer, Effective August 19, 2024

PetMed Express, Inc., Annual General Meeting, Aug 08, 2024

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024

PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer

Recent updates

PetMed Express, Inc. Appoints Robyn DElia as Chief Financial Officer, Effective September 16, 2024

New major risk - Revenue and earnings growth

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

New minor risk - Share price stability

First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Petmed Express, Inc. Appoints Doug Krulik as Chief Accounting Officer, Effective August 19, 2024

PetMed Express, Inc. to Report Q1, 2025 Results on Aug 06, 2024

PetMed Express, Inc.(NasdaqGS:PETS) dropped from Russell 3000 Index

PetMed Express, Inc., Annual General Meeting, Aug 08, 2024

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2024 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024

PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer

PetMed Express, Inc. to Report Q4, 2024 Results on Jun 11, 2024

PetMed Express, Inc. Appoints Justin Mennen to Board of Directors, Effective June 3, 2024

Price target decreased by 21% to US$7.75

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought US$301k worth of stock

CEO, President & Director recently bought US$101k worth of stock

PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Price target decreased by 18% to US$15.00

Now 21% undervalued after recent price drop

A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 9.0% yield

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Consensus EPS estimates fall by 31%, revenue upgraded

Upcoming dividend of US$0.30 per share at 8.1% yield

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on June 12, 2023

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

Now 22% undervalued after recent price drop

PetMed Express, Inc. Appoints Sandra Y. Campos to its Board of Directors

PetMed Express, Inc. to Report Q4, 2023 Results on May 22, 2023

Consensus EPS estimates fall by 20%

The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence

Consensus EPS estimates fall by 48%

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Third quarter 2023 earnings released: US$0.001 loss per share (vs US$0.21 profit in 3Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on February 27, 2023

Investor sentiment improves as stock rises 16%

PetMed Express, Inc. to Report Q3, 2023 Results on Feb 06, 2023

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Price target decreased to US$20.67

PetMed Express, Inc. Declares Quarterly Dividend, Payable on November 30, 2022

Price target decreased to US$21.33

PetMed Express, Inc. to Report Q2, 2023 Results on Nov 07, 2022

PetMed Express Puts Are Compelling

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.30 per share

Now 23% undervalued after recent price drop

PetMed Express CFO to leave post today, by remain with company over transition period

Consensus EPS estimates fall by 15%

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

First quarter 2023 earnings: EPS and revenues miss analyst expectations